Kit de test du cancer colorectal - 3.02.01.4263 - RainSure Scientific - de plomb / pour le gène PIK3CA
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer | Journal of Clinical Oncology
PIK3CA Mutations in Colorectal Cancer. | Download Table
PIK3CA in Colorectal Cancer. - Abstract - Europe PMC
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer | Future Oncology
Molecular Detection of Colorectal Cancer | Encyclopedia MDPI
Frontiers | PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer | Journal of Clinical Oncology
Mutation of the PIK3CA oncogene in human cancers | British Journal of Cancer
Cancers | Free Full-Text | PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
PIK3CA Biomarker | Colorectal Cancer Alliance
Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway | Molecular Medicine | Full Text
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
Frontiers | PIK3CA in Colorectal Cancer
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences
Targeting PI3K Signaling as a Therapeutic Approach for Colorectal Cancer - ScienceDirect
PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival | PLOS ONE
Aspirin Use Not Associated With Survival in PIK3CA-Mutant Colorectal Cancer - The ASCO Post
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN | Molecular Cancer | Full Text
Figure 2 from PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. | Semantic Scholar
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer | Nature Communications
